Henry M. Jackson Foundation for the Advancement of Military Medicine
CytoTest, USU, Henry M. Jackson to Develop Biomarkers for Prostate Cancer
The partners signed a CRADA to develop biomarkers discovered by the Center for Prostate Disease Research for use in clinical diagnostic testing.
PrimeraDx Readying ICEPlex, C. Diff Assay for FDA; Developing Follow-on Infectious Disease Panels
Premium
PrimeraDx, a Mansfield, Mass.-based molecular diagnostics firm, is on track to submit its highly multiplexed PCR-based testing system and associated assay for Clostridium difficile to the US Food and Drug Administration this quarter, CEO Matt McManus said recently.
Rutgers to Use $2.4M Grant to Search for Genes Linked to Suicide Risk
NEW YORK (GenomeWeb News) – The Rutgers Cell and DNA Repository, or RUCDR, has landed a $2.4 million grant from the Henry M. Jackson Foundation for the Advancement of Military Medicine to study mental health risk among service men and women.